Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells

By Fritzer-Szekeres M.   Grusch M.   Luxbacher C.   Horvath S.   Krupitza G.   Elford H.L.   Szekeres T.  

Experimental Hematology, Vol. 28, Iss. 8, 2000-08 ,pp. : 924-930

Elsevier

Access to resources Recommend Favorite

In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors

By Grabarek J.   Darzynkiewicz Z.  

Experimental Hematology, Vol. 30, Iss. 9, 2002-09 ,pp. : 982-989

Elsevier

Access to resources Recommend Favorite

Phase I and pharmacodynamic study of Triapine ( R), a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia

By Giles F.J.   Fracasso P.M.   Kantarjian H.M.   Cortes J.E.   Brown R.A.   Verstovsek S.   Alvarado Y.   Thomas D.A.   Faderl S.   Garcia-Manero G.   Wright L.P.   Samson T.   Cahill A.   Lambert P.   Plunkett W.   Sznol M.   DiPersio J.F.   Gandhi V.  

Leukemia Research, Vol. 27, Iss. 12, 2003-12 ,pp. : 1077-1083

Elsevier

Access to resources Recommend Favorite

Caspases and apoptosis in myelodysplastic syndromes

By Mundle S.D.   Shetty V.T.   Raza A.  

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1310-1311

Elsevier

Access to resources Recommend Favorite

Ribonucleotide reductase: an old target with new potential

By Smith B.D.   Karp J.E.  

Leukemia Research, Vol. 27, Iss. 12, 2003-12 ,pp. : 1075-1076

Elsevier

Access to resources Recommend Favorite